Furthermore, previous studies have shown that the activation of the Shh pathway reduces mitochondrial damage and protects neurons against oxidative stress and apoptosis in autism, PD, stroke, and Down syndrome [1, 17, 25, 39–41, 94, 110], further linking the dysregulated pathways we identified in aFTLD-U. The gene discussed is SHH; the disease is Stroke.